1. A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis. (April 2021) Authors: Lane, N.; Hsu, B.; Visich, J.; Xie, B.; Khan, A.; Dananberg, J. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial. (23rd January 2014) Authors: Westhovens, R.; Bingham, C. O.; Weinblatt, M.; Fleischmann, R.; Keystone, E.; Hsia, E. C.; Hsu, B.; Kim, L.; Mudivarthy, S.; Mack, M.; Goldstein, N.; Braun, J.; Kavanaugh, A.; Mendelsohn, A.; Kay, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0341 Favorable Effects of Sirukumab Treatment on Physical Function and Reductions in Morning Stiffness in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Disease-Modifying Anti-Rheumatic Drugs. (15th July 2016) Authors: Thorne, C.; Takeuchi, T.; Karpouzas, G.; McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Ganguly, R.; Han, C.; Fei, K.; Hsu, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0378 Improvements in Measures of Work Productivity/interference and General Health Status with Sirukumab Treatment in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Anti-Rheumatic Drug Treatment. (15th July 2016) Authors: Takeuchi, T.; Karpouzas, G.; Thorne, C.; McQuarrie, K.; Sheng, S.; Xu, W.; Peterson, S.; Ganguly, R.; Han, C.; Fei, K.; Hsu, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1023 VEGF and CRP Serum Levels Lack Predictive Value for Outcomes as Assessed by Conventional Radiographs and Magnetic Resonance Imaging in Patients with Active Ankylosing Spondylitis Treated with the TNF Inhibitor Golimumab. (10th June 2014) Authors: Baraliakos, X.; Hermann, K.-G.; Xu, S.; Hsu, B.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of high‐performance multicrystalline silicon for photovoltaic industry. (26th October 2013) Authors: Yang, Y. M.; Yu, A.; Hsu, B.; Hsu, W. C.; Yang, A.; Lan, C. W. Journal: Progress in photovoltaics Issue: Volume 23:Number 3(2015) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Engineering silicon crystals for photovoltaics. Issue 9 (11th February 2016) Authors: Lan, C. W.; Yang, C. F.; Lan, A.; Yang, M.; Yu, A.; Hsu, H. P.; Hsu, B.; Hsu, C. Journal: CrystEngComm Issue: Volume 18:Issue 9(2016) Page Start: 1474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0155 Persistent Fatty Lesions in the Vertebrae in Ankylosing Spondylitis FAVOR Subsequent New Syndesmophytes: Imaging Results of the GO-RAISE Study. (10th June 2014) Authors: Baraliakos, X.; Hermann, K.-G.; Xu, S.; Hsu, B.; Braun, J. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0181 Sirukumab, a human anti-IL-6 monoclonal antibody, improves physical function in patients with active ra despite methotrexate therapy: Results from a 2-part, proof-of-concept, dose-ranging, randomized, double-blind, placebo-controlled, phase 2 study. (23rd January 2014) Authors: Hsu, B.; Chiou, C.-F.; Sheng, S.; Smolen, J.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0291 MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a TNF inhibitor. (23rd January 2014) Authors: Machado, P.; Landewé, R.; Braun, J.; Baraliakos, X.; Hermann, K.-G.A.; Hsu, B.; Baker, D.; van der Heijde, D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗